PM0188 is a newly identified sialyltransferase from P. multocida which transfers sialic acid from cytidine 5'-monophosphonuraminic acid (CMP-NeuAc) to an acceptor sugar. Although sialyltransferases are involved in important biological functions like cell-cell recognition, cell differentiation and receptor-ligand interactions, little is known about their catalytic mechanism. Here, we report the X-ray crystal structures of PM0188 in the presence of an acceptor sugar and a donor sugar analogue, revealing the precise mechanism of sialic acid transfer. Site-directed mutagenesis, kinetic assays, and structural analysis show that Asp141, His311, Glu338, Ser355 and Ser356 are important catalytic residues; Asp141 is especially crucial as it acts as a general base. These complex structures provide insights into the mechanism of sialyltransferases and the structure-based design of specific inhibitors. [BMB reports 2008; 41(1): 48-54]
INTRODUCTION
Glucosyltransferases (GTases), a large family containing hundreds of enzymes, catalyze the transfer of sugar moieties from donor sugar molecules to specific acceptor molecules. They can be classified according to both the stereochemistries of substrates and products and the sequence differences among the proteins (1) . Sialyltransferases, a subfamily of the GTases, use the activated nucleotide sugar cytidine 5'-monophosphoneuraminic acid (CMP-NeuAc) as a donor sugar and transfer the sialyl unit to various acceptors sugars (2) . PM0188 is a newly characterized sialyltransferase from Pasteurella multocida (subsP. multocida, strain PM70), which is a pathogen of livestock, poultry, wildlife, and laboratory rabbits and can cause pulmonary disease, sepsis, and meningitis (3) . This enzyme plays important roles in cell-cell recognition, cell differentiation and various receptor-ligand interactions (4) . Furthermore, it is involved in not only biomass synthesis of glycoproteins, glycolipids and polysaccharides but also many complicated details of cellular biochemistry such as protein and lipid glycosylation (5) .
Recently, PM0188 was also described as a multifunctional enzyme that has a2,3-and a2,6-sialyltransferse activity, sialidase activity breaking a2,3-sialyl linkages, and a2,3-trans-sialidase activity (2) . Despite the industrial and medical importance of sialyltransferases, little has been known about their mechanism and detailed molecular structures. Very recently, however, the first sialyltransferase structure in complex with donor analogue and acceptor sugar was reported during preparing this manuscript unfortunately (6) . Independently, we solved the crystal structures of PM0188 in complex with CMP-3FNeuAc and lactose respectively. Here, we determined the crystal structure of PM0188 in complex with a donor sugar analogue and an acceptor sugar simultaneously and suggest a plausible catalytic mechanism of N-acetylneuraminic acid (NeuAc) transfer based on the complex structure. Therefore, this study can provide a framework not only to understand the complexity of bacterial sialylation but also to design and synthesize structurally diverse sialosides as inhibitors.
RESULTS

Overall architecture of PM0188 bound to CMP-3FneuAc
Before we solved the structure of PM0188 bound to CMP-3FNeuAc, we revealed the structures of the apo form and the complex structure with CMP independently. These structures were used as starting models to solve the complex with CMP-3FNeuAc (these two structures are not described; PDB entries are 2C83 and 2C84). To overcome the problem of NeuAc hydrolysis, an inert analogue of the donor sugar CMP-3-fluoro-N-acetyl-neuraminic acid (CMP-3FNeuAc) was synthesized and used to form co-crystals ( Fig. 1A and Fig. 1C ). To solve the structure of the PM0188-CMP-3FNeuAc complex, we tried molecular replacement (MR) using the PM0188-CMP structure as a starting model. In the complex, PM0188 consists of 18 α helices and 12 β strands forming two distinct Rossmann domains of similar topology. There is a deep cleft between the two domains, which is the CMP-3FNeuAc binding site. The binding mode of PM0188 and CMP-3FNeuAc is de-http://bmbreports.org CMP-3FNeuAc is depicted in CPK coloring with carbon atoms in magenta, nitrogen atoms in blue, oxygen atoms in red and phosphorus atoms in orange and with the fluorine atom in bright cyan. (B) Interactions of lactose and active site residues. Lactose is also depicted in CPK coloring with carbon atoms in white and oxygen atoms in red. (C) Movement of Arg63 and Arg313 from apo PM0188 to bound forms is shown in green: CMP bound structure in orange, CMP-3FNeuAc bound structure in yellow, and lactose and CMP-3FNeuAc bound structure in deep teal. scribed in Fig. 2A . Among the binding interactions, the phosphate moiety is stabilized by hydrogen bonds of the OG of Ser355 and water 112 to the O3P. O1P interacts with water 178 and NE2 of His311. The O2P of the phosphate group forms hydrogen bond with NE2 of His311 and O3P also makes hydrogen bonds with OG of Ser355 and ser365. O2P
interacts with OG and main chain nitrogen of Ser356 and hydrogen bonds to water 162 also. The role of His311, Ser355 and Ser356 in the catalytic activity will be discussed later. The present structure exhibits significant closure of the two domains over the CMP binding pocket in the deep cleft just like the CMP-bound binary structure. We found that the NeuAc moiety of CMP-3FNeuAc does not induce any noticeable structural change compared to the CMP-binary structure. The hydrogen networks between the phosphate moiety and His311, Ser355 and Ser365 are identical compared to the CMP-bound binary structure. The 3FNeuAc moiety interacts with some residues in the active site by hydrogen bonds: OAA and OAB with NH2 and NH1 of Arg63, F3A with OD2 of Asp141, O4A with the main chain N of Ser143, O7A with NE1 of Trp270, and O9A with the main chain oxygen of Thr286. Waters 99, 100, 102, 196, and 209 make hydrogen bonds with the NeuAc moiety. This sugar ring of the sialic acid shows a screw boat form which is reminiscent of the NeuAc in the complex structure of CstII-CMP-3FNeuAc. Although this conformation is of higher energy than the normal chair or boat conformation, it could be easily released from the enzyme and a new bond created upon binding of the acceptor sugar.
It was suggested that the disordered domain, α17 helix (residues 373-385), interacts with the NeuAc moiety of CMP3FNeuAc as a part of the lid-like domain (7). In our complex structure, however, this domain is still disordered and there is no direct interaction between the NeuAc moiety and the domain. Generally, the crystal structures of several glycosyltransferase also have at least one flexible loop region which is highly disordered in the apo enzyme. However, when a donor sugar is bound to active site of the enzyme, it is known that this region is well ordered by the interactions with substrate as is shown in the CstII structure with CMP-3FNeuAc (8) . This region (the lid-like domain) normally interacts with the donor sugar directly, to create the acceptor sugar binding site, and to shield the enzyme active site from bulk solvent. The shielding could minimize undesirable side reaction such as hydrolysis of http://bmbreports.org This CMP-3FNeuAc binding mode is distinct to that of CstII (Fig. 3 ). In the complex structure of CstII, the NeuAc moiety is also buried into the active site and makes hydrogen bonds with some residues in the active site as major interactions. On the contrary, in PM0188, the NeuAc moiety is only partially buried into the active site and exposed to solvent except for the ring stacking interaction with the aromatic ring of Tyr270 in the loop between α13 and β8. The phosphate group of CMP-3FNeuAc in CstII is stabilized by Tyr162 and Tyr165 but in PM0188 it is stabilized by hydrogen bonds with Ser355, Ser356 instead of tyrosine residues. In addition, His311 and Wat102 make hydrogen bonds with the phosphate group simultaneously. Although Tyr338 is connected with the phosphate via, the major stabilizing force of the phosphate group is hydrogen bonds by Ser residues, unlike in CstII.
PM0188-CMP-3NeuAc-Lactose complex structure
To reveal the mechanism of NeuAc transfer from CMP-NeuAc to the acceptor sugar, we solved the structure of a complex with lactose as an acceptor sugar along with CMP-3FNeuAc ( Fig.  1B and Fig. 1D ). The structure of the PM0188-CMP-3FNeuAc-lactose complex is very similar with that of the PM0188-CMP3FNeuAc complex (rmsd=0.18 Å for Cα atoms). Lactose is located perpendicularly to the surface between N-terminal and C-terminal domains of the PM0188. The galactopyranose of Lactose makes hydrogen bonds with Asp141 and Arg63 and the glucose moiety interacts with Arg313 by a hydrogen bond. Lactose makes extensive aromatic ring stacking interactions with Trp270, which is expected to be a major contribution to lactose binding (Fig. 2B) . In this structure, the O3' hydroxyl of the galactopyranose is located 5.1 Å from the anomeric carbon C2 of the sialic acid. The distance is too long for the nucleophile to attack the anomeric carbon C2 to make the α2,3-linkage product. Although the lactose is too far away from the sialic acid, the relative orientation and disposition is reasonable considering the other inverting glycosyltransferase structure complexed with acceptor sugar as well as donor sugar analogue such as β-1,4-galactosyltransferase I complex structure (PDB ID 1FGG) (9) . This lactose interaction also shows some similarities with other glucosyltransferase complexes with acceptor sugars: EXTL2 and α1, 3-Galactosyltransferase (α3GT) (PDB entries 1ON8 and 1GWV, respectively) (10). In the crystal structure of α3GT in complex with lactose and Uridine-5-diphosphate (UDP), lactose is located in deep cleft and creates stacking interactions with Trp249 and Trp314, almost lining up parallel with the plane containing ribose and di-phosphate of UDP. However, the disposition between CMP-3FNeuAc and lactose in our PM0188 complex structure is not parallel but in tilted way of 40 o . Most of the glucosyltransferase complex structures with donor and acceptor show similar dispositions with that of α3GT.
The interesting thing in our structure is two arginine residues, Arg63 and Arg313 interacting with CMP-3NeuAc and lactose (Fig. 2C) . The arginine residues are highly conserved in sialidases as well as glucosyltransferases, but not in CstII. It is reported that these arginine residues have a role in substrate interaction and help anchor the substrate during its distortion as the reaction proceeds. In the structure of HemagglutininNeuraminidase, Arg174, Arg416, and Arg498 make the hydrogen bonds with hydroxyl group of its substrate, N-acetyl-D-glucosamine (NAG) and 2-deoxy-2,3-dehydro-N-acetyl-neuraminc acid (11) (The PDB entry is 1E8V). The Influenza B virus neuraminidase also has arginine residues around active site, Arg115, Arg149, Arg291, and Arg373 which interact with sialic acid as well as NAG (12) (The PDB entry is 1NSC). Arg63 and Arg313 in PM0188 have similar features to these enzymes. In the apo form of PM0188, Arg63 makes a hydrogen bond with carbonyl oxygen of Pro34 and a water-mediated hydrogen bond with Ser36, but Arg313 is exposed to solvent. However, in the complex structure with CMP, the side chain of Arg63 is distorted to avoid collision with Arg313 of the loop between α14 and β10. The complex structure with CMP-3FNeuAc shows a Arg63 conformation identical to the apo structure. This makes NH1 and NH2 of Arg63 hydrogen bond with OBA and OAA in the carboxyl group of the NeuAc moiety. In the complex structure of lactose (and also CMP-3FNeuAc), Arg63 still interacts with the NeuAc carboxyl group. However, the side chain of Arg313 moves toward the lactose to allow hydrogen bonding with O2' and O3'. In conclusion, the conformational changes of these two arginines depending on binding partners show the characteristic role of the conserved arginines of glycosyltransferases and sialdases to position the substrate for the forthcoming reaction. 
Kinetic assays of PM0188
To further explore the catalytic roles of the potential key residues identified above, 12 site-directed point mutants of PM0188 were constructed, targeting residues involved in direct contact with the donor and acceptor sugars (Table 1) . It is already known that PM0188 shows mainly α-2,3 activity at pH 7.5-9.0 and α-2,6 activity at pH 4.5-6.5 (2). Therefore, we checked the activities of these mutants at both pH values ( Table 1) . Substitution of His311, which interacts with the nonbridging oxygen in the phosphate group, with Ala (H311A) causes a loss of enzyme activity in pH 8.2 but does not dramatically change its activity in pH 6.5 (4-fold lower than that of the wild type). Substitution of Asp141 with Ala or Asn results in complete loss of both α2,3-and α2,6-activities.
Considering that Asp141 interacts with O3' of lactose, this strongly suggests that Asp141 may play a role as a base to withdraw hydrogen from the 3' hydroxyl group of lactose to make a good nucleophile to attack the anomeric carbon C2 of NeuAc. In addition, Ser336, Glu338, Ser355, Ser356 and Ser356, are also important residues interacting with the donor sugar. Mutant kinetic data shows that kcat values of S355A and S356A indicate no detectable activity at pH 8.2 and a 10-fold and 4-fold lower activity than wild type at pH 6.5. These data indicate that Ser355 and Ser356 hold the phosphate oxygen providing stabilizing force for of CMP-3FNeuAc binding. The E338A mutant also shows no detectable activity at pH 8.2, however, at pH 6.5 the activity is about 5-fold lower than wild type. Glu338 may play a key role in recognition of the donor sugar substrate because the side chain of Glu338 forms a bidentate hydrogen bond with the O2* and O3* of the CMP-3FNeuAc ribose ring. The activities of mutants R63A and R313A, interacting with or relating to lactose, were also measured. The mutant R63A shows about a 2-fold decrease in kcat, while the mutant R313A shows about a 1.2-fold decrease in kcat. This weak effect can be explained from the fact that the distance between the NH1 atom of Arg313 and the O3' of lactose is 3.4 Å, which is too long for a strong hydrogen bond. This suggests that Arg63 and Arg313 play a minor role in the interaction with the acceptor sugar although Arg63 hydrogen bonds with the carboxyl group of the NeuAc moiety. Therefore, Arg63 and Arg313 may be involved in the stabilization of donor and acceptor sugars, but their contribution would be small according to the kinetic data. In addition, there is no significant kinetic change in K309A, which indicates that Lys309 has an additional role in stabilization of the cytosine ring. The kinetic data confirm the important residues interacting with the donor and acceptor sugars. Among them, kinetic data of S355A, S356A and H311A reveal the importance of the stabilization of phosphate. The D141A and D141N mutants show minute or undetectable levels of activity at each pH (pH 6.5 and pH 8.2). These data support our contention that Asp141 acts as a general base by attacking the 6-hydroxyl or 3-hydroxyl group of the galactopyranose in lactose for initiating the sialyltranferase reaction.
DISCUSSION
The structure of PM0188 was solved bound to a donor sugar analogue and an acceptor sugar and revealed C-terminal movement toward the N-terminal domain as a result of donor sugar binding. Most sialyltransferases have active sites including the so-called "sialylmotif" which corresponds to the donor and acceptor sugar binding site (4) . Although PM0188 shows sialyltransferase activity, it does not have a conserved sialylmotif (2) . In addition, it is generally accepted that conventional Rossmann domains contain at least one conserved gly-http://bmbreports.org cine rich sequence, but PM0188 does not have such a sequence, although it has two Rossmann domains (13) . Therefore, the definition of substrate binding residues of PM0188, critical to reveal the mechanism of this multifunctional enzyme, has been elusive. The complex structure of PM0188 bound to CMP-3FNeuAc and lactose clearly identified the substrate binding pockets for both the donor and acceptor and key residues to define the catalytic mechanism. We suggest that PM0188 might follow an SN2-type displacement reaction mechanism to form a glycosidic bond between the acceptor and sugar donor with inversion of the configuration at anomeric carbon C2. This assertion is supported by site-directed mutagenesis, kinetic assays and structural comparision with other inverting glycosyltranferases.
The catalytic mechanism of the inverting glycosyltransferases is well characterized compared to retaining glycosyltransferases. Until now, crystal structures of donor-acceptor complexes of the inverting glycosyltransferases 4Gal-T1, GnT I and GlcAT-I have been reported, which provided evidence for the relative orientation of donor and acceptor in the catalytic pockets. In these structures, the hydroxyl group of the acceptor is located about 3 Å away from the anomeric carbon of the donor. Acidic residues such as a glutamic or aspartic acid deprotonate the hydroxyl group of the acceptor, enabling a nucleophilic attack on the anomeric carbon atom of the donor. Through an oxocarbenium-ion-like transition state, these enzymes form a glycosidic bond between the acceptor and sugar donor with inversion of the configuration at C1. The transition state of sialic acid in the sialyltransferase-catalyzed reaction is also believed to have oxocarbenium ion-like character at the anomeric carbon. But in sialyltransferase structures, the pyranose ring conformations of sialic acid are in chair conformation. Therefore, the ring needs to be distorted to generate the planar oxocarbenium ion like transition state. Arg63 is thought to help this distortion along the reaction coordinate by interaction with the sialic acid carboxylate. This arginine anchoring is also shown in the sialidase and trans-sialidase arginine triad (10) .
The structures presented here have identified Asp141 as a potential catalytic base in α2,3-and α2,6-sialyltransferase activity. This has been confirmed by site-directed mutagenesis and kinetic assays. The D141A mutant did not show any detectable α2,6-sialyltransferase activity and decreases the α2,3-sialyltransferase activity by more than 55-fold. This supports that as a catalytic base, Asp141 withdraws a proton from the O3' hydroxyl of the galactose pyranose. The withdrawal makes the negatively charged oxygen a better nucleophile to attack the anomeric carbon of the sialic acid in the donor, consistent with the mechanism of inverting glycosyltransferases.
From the structural analysis of PM0188 structures, we could propose the mechanism of PM0188 NeuAc transfer through an oxocarbenium ion-like transition state with general base assistance (Fig. 4) . The nonbridging oxygens of phosphate are stabilized by hydrogen bonds with Ser355, Ser356 and His311. So, we assume direct cleavage between the anomeric carbon C2 of NeuAc and the oxygen of the phosphate because hydrogen bonds between Ser355, Ser356 or His311 and nonbridging oxygens build up enough positive charge in the phosphate to break its ether bond. In the acceptor sugar, the 6-hydroxyl or 3-hydroxyl group of the galactose can act as a nucleophile owing to a general base, and then directly attack the anomeric carbon C2 of NeuAc with inversion of the C2 configuration in step 2. This reaction creates a α2,3-or α2,6-glycosidic linkage with lactose in step 3.
The crystal structures of PM0188 bound to a donor sugar analogue and an acceptor sugar provide insights into the catalytic mechanism of this important enzyme and identify the key residues in sialyltransferase activity. This will be useful for understanding the mechanism of other sialyltransferases and the structures of other GTases. Moreover, this structure will provide a solid foundation for design of novel sialyltransferase inhibitors.
MATERIALS AND METHODS
Protein expression, purification, crystallization and data collection
The expression, purification and crystallization of Seleno-methionine (Se-Met) containing PM0188 proteins were carried out as described previously (14) . To obtain co-crystals with CMP-NeuAc, CMP-3FNeuAc which is the donor analogue http://bmbreports. Rfree is the R-factor calculated by using 5% of the reflection data chosen randomly and omitted from the start of refinement. with the fluorine in the axial position at C3 of the Neu5Ac pyranose ring, and CMP-3FNeuAc/lactose, 1.5 μl of the protein was mixed with 1.5 μl of a solution containing 30% PEG 3350, 0.1 M Bis-Tris, pH 6.5, 25 mM MgCl2, 5 mM CMPNeuAc, CMP-3FNeuAc as the donor sugar and 5 mM lactose as the acceptor sugar. Data collection of PM0188-CMP3FNeuAc co-crystals were conducted under the same conditions with that of apo crystals (14) . And, data on PM0188-CMP-3FNeuAc-lactose were collected under the same conditions as PM0188 on a home source Rigaku X-ray generator using a RaxisIV ++ image plate. Data were indexed, integrated, and scaled using Denzo, XDisplayF, and Scalepack (15) .
Structure determination and refinement
The PM0188 structure was solved by MAD phasing from monoclinic crystals (P21) grown with protein containing six incorporated Se-Met residues (14) . The initial model was built using the program O (16) and was improved by using positional and individual B factor refinement as well as the addition of water molecules to the model. The apo PM0188 structure was used as a starting model to solve the CMP bound structure by molecular replacement. To solve the complex structure with CMP-3FNeuAc and CMP-3FNeuAc/lactose, the PM0188-CMP structure was used as an initial model. All structures were refined with the program CNS 1.1 (17) using 95% of the measured data. The quality of the model was checked by PROCHECK (18) . The final R-factor and R-free (along with the models) are listed in Table 2 . The final coordinates and the structure factors have been deposited in the Protein Data Bank (PDB ID 2C83, 2C84, 2IY7, and 2IY8).
Site-directed mutagenesis
To confirm the catalytic roles of the residues interacting with donor and acceptor sugars, 12 site-directed mutants were constructed. The DNA fragments encoding the mutants (S36A, D141A, D141N, H311A, S336A, E338A, S355A, S356A, S355A/S356A, R63A, R313A, and K309A) were cloned into pET15b using the splicing by overlap extension (SOE) method (19) . The PM0188 mutants were over-expressed and purified by the same method as native PM0188.
Kinetic assays
Kinetic studies were performed by Palcic et al.'s continuous coupled assay (20) . Briefly, all kinetic parameters were ob-http://bmbreports.org tained by varying the lactose concentration from 0.25-5.0 mM (0.25 mM, 0.5 mM, 1 mM, 3 mM, 5 mM) at a fixed concentration of CMP-NeuAc (1 mM) at 37 o C in a buffer containing 50 mM HEPES, pH 6.5 (or pH 8.2), 0.8 mM NADH, 1 mM PEP (phosphoenol pyruvate), 2 mM ATP, 20 mM MgCl2, 7.5 U of pyruvate kinase, 15 U of lactate dehydrogenase, 10 mU of nucleotide monophosphate kinase and 1 ng of sialyltransferase. α2,6-(or α2,3-) transferase activity was monitored by the enzymatic oxidation of NADH coupled to the released CMP using a Multiskan spectrum UV-vis spectrophotometer at 340 nm. Kinetic parameters were obtained from reciprocal LineweaverBurke plots of the average values of triplet assays.
